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Distribution of Aerosolized Particles in Healthy and Emphysematous Rat Lungs:
Comparison Between Experimental and Numerical Studies
Jessica M. Oakes1,2, Alison L. Marsden3, Celine Grandmont1,2, Chantal Darquenne4, Irene E. Vignon-Clementel1,2,∗
Abstract
In silico models of airflow and particle deposition in the lungs are increasingly used to determine the therapeutic
or toxic effects of inhaled aerosols. While computational methods have advanced significantly, relatively few stud-
ies have directly compared model predictions to experimental data. Furthermore, few prior studies have examined
the influence of emphysema on particle deposition. In this work we performed airflow and particle simulations to
compare numerical predictions to data from our previous aerosol exposure experiments. Employing an image-based
3D rat airway geometry, we first compared steady flow simulations to coupled 3D-0D unsteady simulations in the
healthy rat lung. Then, in 3D-0D simulations, the influence of emphysema was investigated by matching disease
location to the experimental study. In both the healthy unsteady and steady simulations, good agreement was found
between numerical predictions of aerosol delivery and experimental deposition data. However, deposition patterns in
the 3D geometry differed between the unsteady and steady cases. On the contrary, satisfactory agreement was not
found between the numerical predictions and experimental data for the emphysematous lungs. This indicates that
the deposition rate downstream of the 3D geometry is likely proportional to airflow delivery in the healthy lungs, but
not in the emphysematous lungs. Including small airway collapse, variations in downstream airway size and tissue
properties, and tracking particles throughout expiration may result in a more favorable agreement in future studies.
Keywords: Airflow, Particle deposition, Multi-scale, Aerosol exposure experiments, Computational fluid dynamics
1. Introduction
Computational fluid and particle dynamics simulations provide detailed spatial and temporal distributions of air-
flow and particles in healthy and diseased lungs. However, to increase confidence in these models, results must be vali-
dated against in vivo experimental data. While several groups have shown good agreement between three-dimensional
(3D) flow (6; 19) and particle-based (14; 15; 16; 35; 32) models with in vitro experiments, these comparisons are not
sufficient for validation of in vivo conditions. While one-dimensional (1D) particle transport models have relatively
well predicted in vivo data of total and regional deposition in the human (5; 2; 13) and rat lung, (27; 1) they do not
provide detailed spatial information. Recently, Minard et al. (17) showed promising agreement between in silico
predictions and in vivo magnetic resonance (MR) derived flow fields in rat lungs. While these previous studies have
advanced the validity of computational models, none of them compared multi-scale simulations to regional particle
deposition data in both healthy and diseased lungs.
Emphysema, a disease characterized by increased tissue compliance, expanded acinar volume, and decreased
small airway diameter compared to normal, (31) has been shown to impact particle deposition in the lungs (20; 30; 4).
To study the influence of emphysema-like morphometric changes on particle deposition, we previously (20) employed
MR methods (24) to determine lobar deposition in elastase-treated and healthy rat lungs. Results showed, for rats
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ventilated with the same breathing parameters, that particle concentration was higher in the elastase-treated lungs,
compared to the healthy lungs. However, the distribution of particles to the lobes was the same in the healthy and
emphysematous rats (20) despite the MR and histological measurements suggesting heterogeneous distribution of
emphysema-like structures in several lobes of the emphysematous group.
Recently, we developed a 3D-0D coupled numerical model to study airflow and particle deposition in healthy
and emphysematous rat lungs (22) that was parameterized from the experimental data of Oakes et al. (20). The
goal of the current study was to extend this previous 3D geometric model (23) and to compare regional deposition
predictions to experimental data (20). These simulations required matching the numerical model as closely as possible
to the experimental conditions and comparing the predicted distribution of inhaled particles to the experimental lobar
deposition. Using this in silico model, we explored the influence of flow conditions (unsteady versus steady) and
initial particle spatial distribution on deposition and lobar delivery.
2. Methods
2.1. Multi-Scale Numerical Airflow Framework
The numerical framework has been previously described in Oakes et al. (22). The 3D geometry was created
with a custom version of the open source software, SimVascular (simvascular.org) (28) and includes up to 16 airway
generations, with 81 terminal airways (Figure 1) (23). Airflow was simulated with an open source stabilized finite
element Navier-Stokes solver, assuming rigid walls and incompressible Newtonian flow (density = 1.2 x 10−6 gmm3 ,
viscosity = 1.81 x 10−5 gmm−s ). A custom linear solver was employed, incorporating resistance-based preconditioning
with a combination of GMRES and conjugate gradient methods (9). Three respiratory cycles were simulated with
six Newton iterations of the linear system within each time step of 10−4 s. Anisotropic mesh adaptation based on
the Hessian of the velocity field was employed to ensure mesh convergence of the solution (18) using meshsim
(Simmetrix, Troy NY). Mesh convergence was confirmed for both the flow field and particle deposition.
A no-slip boundary condition was assigned at the airway walls, the experimentally measured time-varying pressure
(PH(t) or PE(t), H: healthy, E: Emphysema) (22) was applied at the trachea face (Figure 1A) and 0D resistance (Ri, j)
and compliance (Ci, j) models (3) were implemented at each distal face by implicitly coupling the 0D models to the 3D
model (11). A representative healthy and emphysematous rat were chosen to match the rat-specific global parameters
with its pressure curve. The 0D model is governed by the following equation:
Ri, j
dV(t)i, j
dt
+
V(t)i, j
Ci, j
= P(t)i, j − Ppeep, (1)
where Vi, j is the inspired volume, P(t)i, j is the pressure at each distal face and the j and i indices identify the distal
faces, with lobe j and assigned airway number i. Ppeep is the constant pressure of 1 cmH2O (20). Note that the distal
pressure PD in Figure 1 does not appear in this equation as it describes the evolution of the inspired, not the total,
volume (22). To prevent numerical instability a convective stabilization scheme (10) was imposed at all faces with
β = 0.1. The resulting resistance in the 3D geometry was calculated at the time of maximum inspiration (R3D,insp) and
expiration (R3D,ex) by dividing the average pressure drop in the 3D geometry by the flow rate at the trachea.
In the next two paragraphs, the parameters Ri, j and Ci, j were derived using a combination of the experimental
measures and a purely 0D model (e.g. Figure 1 C). With this formulation, it was assumed that the 3D resistance did
not influence the average flow repartition in the distal branches of the 3D tree. Therefore, the driving pressures, PH(t)
or PE(t) (Figure 1 A) remained the relevant P(t)i, j for these solely 0D models. This assumption was tested and its
validity is confirmed in the discussion section.
Healthy 0D Parameters
The 0D model parameters for the healthy simulations were defined as:
Ci, j =
Ai, jα jCglobal
AT j
(2)
Ri, j =
RglobalAT j
α jAi, j
, (3)
2
where α j is the volume of each lobe divided by the total volume of the lung derived from imaging data at total lung
capacity (23), Ai, j is the cross-sectional area of each distal face and AT j =
Nairway∑
i=1
Ai, j. The global parameters were set
to the values previously determined from the experimental data (Rglobal = 0.098 cmH2O − s − cm−3, Cglobal = 0.236
cm3 − (cmH2O)−1) (22). With these definitions Ri, j and Ci, j are functions of both the fractional cross-sectional area
and experimentally-measured lobar volume fraction α j. Neglecting the 3D region as explained above, all the distal
RC 0D models in parallel are mathematically equivalent to a single global RC 0D model. This is due to the fact that
the products Ri, jCi, j are all equal, i.e. their relaxation times are the same. Following our previous work (22), the 0D
resistance during expiration was set to 1.5 times the 0D resistance during inhalation (Ri, jex = 1.5Ri, j) (26).
In addition to the unsteady simulations, two steady simulations were performed in which either a constant mean
(7408 mm
3
s ) or maximum (12025
mm3
s ) inhalation flow rate was set at the inflow trachea face and Ri, j were applied as
the outlet boundary conditions at the distal faces.
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Figure 1: 3D airway geometry (23) used for all the simulations. Panel A: Identification of the airways leading to the
five lobes. Panel B and C: Definition of the zones used for the emphysematous simulations. Zone 2 (diseased region)
was set to be at the bottom 1/3 of the left, cardiac and diaphragmatic lobes. Zone 1 (normal region) was defined as the
top 2/3 of the left, cardiac and diaphragmatic lobes and the entire apical and intermediate lobes. Panel C shows the
distribution of the normal (Rnorm and Cnorm) and diseased (Rdis and Cdis) parameters for each zone.
2.2. Emphysema 0D Parameters
Emphysematous regions were heterogeneously located in the lung to match the experiments (20). The lung was
divided into normal (Zone 1) and diseased (Zone 2) regions (Figure 1B). Due to this heterogeneity, a new procedure to
estimate the distal parameters was designed, based on a purely 0D model. In fact, several RC models in parallel are not
mathematically equivalent to a single RC model when the characteristic times, that is, the products τ = RC are not the
same. Within each homogeneous region (normal or diseased) these products are the same by construction. However
between regions, this is no longer true, that is, a diseased RC and a normal RC in parallel are no longer formally
3
equivalent to a global RC model. [Note that only the global compliance, and not the global resistance, changed for
the emphysematous rats compared to the healthy rats (22), resulting in different relaxation times between these two
states.] As a result, the relationship between experimentally determined global R and C, and lobar or sublobar values
is no longer simple. Ri, j and Ci, j cannot be described as they were for the healthy simulations, inversely, or directly,
proportional to the volume and area fractions. However, they can be determined with a 0D model, in which each
homogeneous region (normal or diseased) is represented by a single RC model (Figure 1C).
As the airways in Zone 1 are normal, they were assigned the same Ri, j, Ri, jex and Ci, j as in the unsteady healthy
simulations. The inspired volumes, V j, of the two normal lobes were calculated by directly solving:
Rnorm j
dV j
dt
+
V j
Cnorm j
= PE(t) − Ppeep, (4)
where Rnorm j =
1
N j∑
i=1
1
Ri, j
and Cnorm j =
N j∑
i=1
Ci, j. N j is defined as the total number of airways within Zone 1 of each lobe j.
The total inspired volume VTdis of the three diseased lobes (diaphragmatic, cardiac, and left lobes) were found by
subtracting the volume delivered to the apical and intermediate lobe from the total inhaled volume (2.2 mL) (22). The
remaining volume was distributed amongst the three diseased lobes with VE j =
VTdisα j
3∑
j=1
α j
. For Zone 1 (i.e. the healthy
part) of the diseased lobes, V j was calculated directly with Eqn. 4 for Rnorm j and Cnorm j of Zone 1 and was subtracted
from VE j to find the total inspired volume of the diseased part of each diseased lobe, Vdis,insp j . Then,
Rdis j
dVdis j
dt
+
Vdis j
Cdis j
= PE(t) − Ppeep (5)
was inversely solved and unique Rdis j and Cdis j were found to satisfy Vdis j (t = tinsp) = Vdis,insp j . Ri, j and Ci, j of the
terminal airways in Zone 2 were then distributed according to:
Ci, j =
Ai, jCdis j
ATdis j
(6)
Ri, j =
Rdis j ATdis j
Ai, j
, (7)
where ATdis, j is the total cross-sectional area of the terminal airways within Zone 2 of each lobe.
2.3. Particle Tracking and Comparison to Experimental Data
Following the airflow simulations, monodisperse inert particles (diameter = 0.95µm, density = 1.35g − cm−3)
were tracked throughout inspiration using Lagrangian methods to solve a reduced form of the Maxey-Riley equation
(29; 22). The particles were released at the trachea face throughout inspiration, and the number of particles released
was either assigned to be proportional to the local flow rate at the particle starting location (staggered release) or
constant in both space and time (uniform release). The gravity vector direction was set to simulate a rat in the supine
position. Particles were assumed to have either deposited or exited once they left the 3D geometry at either the airway
walls or one of the distal faces, respectively. Particle deposition was checked to be independent of both the time step
and number of particles released. The percentage of deposited particles was calculated by normalizing the number of
particles deposited by the number of particles inspired. Normalized particle delivery to each lobe was calculated by
PDel j =
N j∑
i=1
Nexiti, j + Nwall j
5∑
j=1
(
N j∑
i=1
Nexiti, j + Nwall j )
, (8)
4
where Nexiti, j is the number of particles to exit each distal face and Nwall j is the number of particles to deposit on the
walls of the airways within lobe j of the 3D geometry. The volume normalized particle delivery, VPDel j , was calculated
for each lobe by
VPDel j =
PDel j
α j
. (9)
Both PDel j and VPDel j were compared to the experimental values of PDep j and VPDep j , respectively (20). Note that
VPDep j was found by normalizing PDep j by each rat’s α j found in the experimental study. (20)
3. Results
3.1. Resistance and Compliance Identification
Parameter results are presented in Table 1. Rdis j was smaller and Cdis j was larger in Zone 2 of the emphysematous
lungs compared to Zone 2 of the healthy lungs (Table 1). The relaxation time constant, τ = RC, was the same for all
lobes in the healthy simulations (Table 1). For the emphysematous simulations, Zone 1 had the same τ as the healthy
simulations. However τ in Zone 2 was larger in the emphysematous lungs compared to the healthy lungs (Table 1).
3.2. Multi-scale CFD Simulations
Five mesh adaptions were performed and the fourth mesh (∼ 3 million elements) was used for all simulations.
Particle deposition was sensitive and slow to converge with mesh refinement despite there being little difference in the
flow field between mesh adaptions. Tuning of Ri, j was not necessary, as the difference in inspired volume between the
0D model prediction and the 3D simulation result was only 2%. Additionally, the normalized lobar tidal volume was
the same as α j for the healthy case but not for the emphysematous case (Table 2). The flow distribution was mainly
driven by the compliance, as the pressure drop given by Vi, jCi, j of Eqn. 1 was ∼10 times greater than the pressure drop
given by Ri, j
dVi, j
dt . For Zone 1, the percentage of total flow delivery was less in the emphysematous lungs compared to
the healthy lungs (Table 1 and Figure 2). Conversely, the delivery of air to Zone 2 was higher in the emphysematous
rats compared to the healthy rats (Table 1 and Figure 2). Zone 2 of the emphysematous simulations took longer to
empty, as evident by their slower relaxation rates, τ (Table 1), compared to the same regions of the healthy lung
(Figure 2). In the emphysematous simulations the diseased regions finished filling after the normal regions (0.384 s
vs 0.360 s).
3.3. Flow Profiles in the 3D Geometry
The velocity profile at the trachea entrance was mainly parabolic throughout inspiration and became biased to-
wards the right lung as the flow approached the main carina (Figure 3). The flow slows down as it travels deeper into
the lung (Figure 3), since the total cross-sectional area of the 3D geometry increases with increasing generation. As
seen previously (22), the flow patterns were highly dependent on the time-point in the breathing cycle (t=0.091 s and
t=0.258 s, same flow rate, Figure 3B) as demonstrated in Figure 3C and E for the healthy case and Figure 3D and F
for the emphysematous case.
The main bronchi’s cross-sectional area increased along their length (23), which caused an adverse pressure gra-
dient along the main bronchioles (Figure 4). The opposite effect occurred for the terminal airways; the cross sectional
area decreased along their length, which created an enhanced pressure drop (Figure 4) and increased flow velocity
(Figure 3). The time-averaged resistances in the 3D geometry were larger than predicted by both Poiseuille’s model
and with Pedley et al.’s (25) correction (Table 3).
Steady vs. Unsteady: Contrary to the unsteady simulations, the normalized lobar flow distribution for the steady
simulations did not match the normalized lobar volume, α j (Table 2). The largest deviation was for the intermediate
lobe of the steady mean inflow case, where 25% more flow was delivered than expected based on the assumption that
the flow distribution is proportional to the lobar volume. This resulted in higher velocity magnitudes in the airways
leading to this lobe, compared to the unsteady simulations at the same time point (Figure 3A vs. Figure 3C and E).
The pressure drop in the steady simulation at maximum inhalation was 26% greater than the unsteady simulation
(Figure 4A vs B).
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Figure 2: Volume of air entering each zone of each lobe (zone definition is given in Figure 1B) and the total lung
(bottom right panel) for the healthy and emphysematous simulations.
Healthy vs. Emphysematous: In the emphysema case, the flow velocities were higher in Zone 2 and lower in Zone
1 compared to the same regions of the healthy simulations (Figure 3D vs C and Figure 3F vs. E). This difference is
especially apparent during the deceleration phase of inhalation (Figure 3E and F), likely caused by the airflow phase
shift between the two zones in the emphysematous lungs (Figure 2). The flow reverses direction and moves towards
the trachea in all the airways at the start of expiration for the healthy simulation (Figure 3B and Figure 3G)). However,
in the emphysematous simulation, the air is both moving away (Zone 2) and towards (Zone 1) the trachea at the start
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Subtending Lobe Healthy Unsteady Steady: Mean Steady: Maximum Emphysema
Volume, α j ∗ 100 Tidal Volume, % Flow, % Flow, % Tidal Volume, %
Apical 11.0 11.0 11.9 11.1 8.06
Intermediate 13.5 13.5 18.1 14.2 9.90
Diaphragmatic 28.0 28.0 27.9 26.8 30.7
Cardiac 11.6 11.6 10.4 11.4 12.0
Left 35.9 35.9 31.7 36.4 39.2
Table 2: Subtending lobe volume percentage (α j) (23), inhaled percent lobar volume for the unsteady simulations,
and percent lobar flow division for the two steady simulations.
of expiration (Figure 3H), creating asynchrony between the two regions.
While the pressure drop in the 3D geometry is quite similar at maximum inhalation (Figure 4 A and D), the average
pressure drop during peak exhalation in the emphysematous lungs was 36% of the pressure drop in the healthy lungs
(Figure 4 F vs C). The maximum 3D resistance in the 3D geometry was smaller in the emphysematous simulations
compared to the healthy simulation for both inspiration and expiration (Table 3). However, the time-averaged 3D
resistance was nearly the same (Table 3) between the two simulations.
3.4. Particle Deposition in the 3D Geometry
There was negligible difference in total particle deposition between the healthy (2.82%) and emphysematous
(2.98%) simulations. Similar to our previous study (22), particles deposited mainly at the bifurcation zones and back-
side (in the direction of gravity) of the 3D geometry (Figure 5) for both the healthy and emphysematous simulations.
The relative difference in the percentage of deposited particles in the uniform seeding was 1.5% of the staggered
release. Deposition in the 3D geometry was 6.0% less and 6.6% greater than the unsteady simulations for the mean
and maximum steady simulations, respectively. Additionally, while the particle deposition sites were spread out in
the unsteady simulations, particles tended to pile up in the steady simulations, creating regions of higher particle
concentration (Figure 5C and D).
The distribution of deposition in the 3D geometry was impacted by the disease (Figure 6A). The percentage of
particles depositing on the airway walls was higher in Zone 2 and lower in Zone 1 in emphysema compared to the
healthy simulations (Figure 6A). The concentration of deposited particles was highest in the apical lobe, compared to
the other four lobes (Figure 6B) for both the healthy and emphysematous simulations. Particle concentration in Zone
2 was higher in the emphysematous than in the healthy simulations (Figure 6B). Figure 6C shows that the apical lobe
had the greatest and the intermediate lobe the smallest number of particles depositing on the wall, when normalized
by the flow rate percentage, for both the healthy and emphysematous simulations.
3.5. Particle Distribution: Comparison to Experimental Deposition
There was excellent agreement between the experimental deposition data, PDep, and the simulated lobar delivery,
PDel, for the steady and unsteady healthy simulations (Figure 7A). PDel was slightly lower and slightly higher than
PDep for the apical and cardiac lobes, respectively. While there was no statistical difference (t-test, p>0.5) between
VPDep and VPDel, VPDep was greater than 1 for the apical and intermediate lobe.
The distribution of particle delivery to the 5 lobes was highly dependent on the seeding profile (Figure 7A);
uniform seeding overestimated PDel to the left lobe and underestimated PDel to the diaphragmatic lobes compared to
PDep (Figure 7A).
For the three diseased lobes, good agreement was found between PDel and PDep for the emphysematous simu-
lations (Figure 7B). VPDel of particles in the emphysematous simulations (Figure 7D) matched VPDep for only the
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Inspiration Expiration
Maximum Time-Averaged Maximum Time-Averaged
Healthy 0D-3D Simulation 0.087 0.020 ± 0.010 0.196 0.024 ± 0.014
Emp. 0D-3D Simulation 0.056 0.021 ± 0.007 0.061 0.024 ± 0.009
0D (22) – 0.098 – 0.147
Poiseuille 0.003 0.003 0.003 0.003
Pedley’s Correction (25) – 0.007 – –
Table 3: Resistance ( cmH2O scm3 ) in the 3D geometry calculated from pressure drop found from the 0D-3D simulations
and from empirical formulas. Maximum and time-averaged simulated resistances were calculated by taking the mean
pressure drop from the trachea to each of the distal faces and by dividing it by the flow rate at the trachea. Resistances
calculated with either Poiseuille (Rp =
8µl
pir4 , where l and r are the length and radius of the airway, respectively) or
Pedley et al.’s correction (25) (Rped =
1.85Rp
4
√
2
√
Re2r
l , where Re is the Reynolds number) were done so by systematically
summing up the resistance in each airway by moving from the most distal regions of the tree towards the trachea.
diaphragmatic and cardiac lobes; volume normalized delivery was overestimated in the left lobe and underestimated
in the apical and intermediate lobes.
4. Discussion
The goal of this current study was to compare simulated particle delivery in healthy and emphysematous lungs to
in vivo experimental data. To do this, 3D-0D in silico models were created to represent the experimental conditions.
Favorable agreement was found for the healthy simulations, however, as the peripheral deposition efficiency differs
between diseased and healthy regions of the lung, similar agreement was not found for the emphysematous lungs.
4.1. Particle Deposition and Distribution
4.1.1. Steady vs Unsteady Simulations
Despite steady and unsteady simulations velocity differences (Figure 3), both reasonably predicted the healthy
experimental particle lobar distribution (Figure 7A). This finding suggests that if only lobar particle delivery is needed
and there is little influence of inertia on the particle transport, then steady simulations may be appropriate. However,
if one aims to predict locations of high particle concentration, then steady simulations may not be sufficient (Figure
5).
4.1.2. Staggered vs. Uniform Release
There was good agreement between the experimental deposition and the particle delivery to the lobes for the
staggered release, but not for uniform release (Figure 7A). In the latter, the number of released particles was uniform
throughout inspiration, independent of the particle’s starting location. Slow and fast streamlines carried the same
number of particles, causing an unrealistically high (left lobe) or low (diaphragmatic lobe) delivery to areas of the
lung which they fed. However, the 3D deposition number was relatively unaffected by this seeding density profile.
The staggered release best represents the exposure experiments: a long tube led to the trachea (20), causing particles
to convect with the fully developed flow. In agreement with previous work (35), particle distribution in the lung
is sensitive to the seeding method and therefore care should be taken when choosing how to initially distribute the
particles.
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4.1.3. Influence of Airway Geometry
While not statistically different than unity (20), VPDep in the apical lobe tended to be larger than predicted by α j
for the healthy case (Figure 7C). Since the simulated apical VPDel was close to unity (Figure 7C), lobar ventilation or
geometric differences may explain this enhanced deposition. The apical ventilation may be greater than assumed by
α j, resulting in increased particle delivery and thus deposition. Deposition efficiency could also be greater since the
apical lobe exhibits dichotomous branching characteristics, while the other lobes branch monopodially (23). Indeed,
the apical short branching structure and high surface area to volume characteristics caused enhanced deposition in this
3D region (Figure 6B). The apical lobe also has a shorter path length to the acinus than the other lobes (34), which
may result in a higher particle concentration delivery to the acinus and therefore enhanced deposition in this region.
The opposite was found for the intermediate lobe, where the branching structure is highly monopodial.
As particles are transported by convection in the conducting airways fewer particles were delivered to lower flow
areas. However, lower velocity also means more time to sediment and deposit on the wall. For example, in the
diseased cardiac lobe, flow rate and particle delivery increased in emphysema, but particle deposition was higher in
the healthy simulations (Figure 6C). The opposite effect was seen for the diaphragmatic lobe (Figure 6C).
4.1.4. Particle Deposition in Emphysema
Experimental total deposition was higher in emphysema. However, these results were not replicated computation-
ally: total 3D deposition was not influenced by the heterogeneous disease. As this 3D geometry only consists of about
4% (23) of total lung volume, this enhanced deposition may occur downstream of the considered geometry, or during
expiration. Furthermore, even though there was asynchrony in the filling and emptying of the lobes in the emphyse-
matous simulations (Figure 3H), this only occurred for a short period of the respiration cycle. It is possible that this
asynchrony becomes more significant as the disease progresses, causing air to be trapped. Particles suspended in this
trapped air will likely have time to sediment and deposit. This failure to flush out potentially harmful particles could
contribute to accelerated disease progression.
The numerical simulations were unable to fully reproduce the emphysema PDep (Figure 7B and D). Particle de-
livery was not proportional to lobar volume in the emphysema case (Figure 7D). While measured lobar volume was
similar between healthy and emphysematous rats (20), computed airflow and hence particle delivery were enhanced
in the diseased regions because of their higher compliance. As the inspired air volume distribution no longer followed
the lobar volume fraction, lobar particle delivery was no longer proportional to α j in contrast to the healthy rat case
(Figure 7D vs C).
Deposition efficiency in diseased and healthy regions are likely to be different with less deposition occurring in
the large acinar airspaces of the diseased lung parenchyma (31; 21). However, reduced traction of the emphysematous
tissues on the adjacent small airways decrease their size, potentially increasing small airway deposition. Additionally,
small emphysema airways are prone to collapse, (33) likely causing local particle trapping, enhancing sedimentation.
But, flow is slower in normal regions (Figure 3), potentially favoring sedimentation in these regions. These contradict-
ing effects make it difficult to predict the behavior of particles downstream of the 3D model and should be examined
in future simulations.
5. Limitations
Constant Ri, j, Ri, jex and Ci, j values were used for the 0D model parameters, even though they most likely change
throughout inhalation and exhalation. However, it was not possible to define time varying Ri, j, Ri, jex and Ci, j, as only
constant Rglobal and Cglobal could be found from the experimental data (22). As the particles exhibited little inertia, it
is unlikely time varying Ri, j and Ci, j parameters would impact the particle distribution to the lobes.
While measured experimentally with MRI, (20) there is some uncertainty in the uniformity and location of the
disease in the emphysematous lungs. Simulations would benefit from more detailed knowledge of disease location,
perhaps measured experimentally by ventilation (12; 8), tissue compliance or sub lobar volumes. While regional
ventilation maps in elastase-treated rat lungs (7) exist, it is difficult to apply them to numerical simulations, although
(sub-)lobar information would be highly valuable in parameterizing multi-scale simulations.
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6. Conclusions
This study was the first to compare 3D numerical particle deposition simulations to experimental data in both
healthy and diseased conditions. While both the steady and unsteady simulations reasonably predicted the lobar
distribution of particles in the healthy case, the deposition patterns in the 3D geometry was quite different between
the two. This finding indicates that if only lobar distribution is needed, steady simulations may be appropriate for the
flow and particle properties considered in this study. However, unless the flow delivery to each lung region is known
beforehand, emphysema can only be modeled using the unsteady multi-scale techniques employed in the current
study. Unlike for the healthy simulations, we were unable to match the emphysema experimental data. This was
likely because the airways and pulmonary region downstream of the 3D geometry were lumped in the RC models. In
the healthy simulations, it is possible that deposition efficiency downstream of the 3D geometry is relatively similar
between lobes. However, in emphysematous lungs, where normal regions are neighboring diseased regions, the
deposition efficiency is likely not the same between these different areas of the lung. Therefore factors such as
enhanced deposition in the normal acinus regions compared to the diseased regions, smaller airway diameters in
diseased regions compared to normal regions, airway collapse in diseased regions, and particle transport through
expiration, may impact deposition efficiency downstream of the 3D geometry considered in this study.
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Figure 3: Velocity magnitudes and streamlines ( cms ) for the mean inflow steady simulation (A) and the unsteady healthy
and emphysematous simulations at the time of mean inspiration before and after the time of maximum inhalation
(Healthy: panels C and E, Emphysematous: panels D and F). For visualization purposes the top portion of the trachea
is removed in the figure. The velocity magnitude of the bottom part of the left lung (for location see panel E) at the
end of inhalation is shown for the healthy (G) and emphysematous (H) simulations. The same phenomenon occurs at
the intersection of Zone 2 and Zone 1 in the cardiac and diaphragmatic lobes. Arrows show the general flow direction.
The time points where the flow field was plotted for each panel is shown in panel B.13
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Figure 6: Panel A: Percent of particles depositing on each region of the 3D geometry, normalized by total number
of particles simulated. Panel B: Percent of particles depositing on wall normalized by the volume of the conducting
airways of each region. Panel C: Percent of particles depositing on wall, normalized by the number of particle
depositing (Panel A), divided by the percent flow received by each region. Zone 2 only included the airways that led
to only Zone 2, as defined in Figure 1B.
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Figure 7: Panels A and B: Comparison of PDel and PDep (20) for the healthy (uniform and parabolic seeding, panel A)
and the emphysematous (panel B) rats. The particle delivery results for the steady simulations at mean and maximum
inhalation flow rate are shown in panel A. Panels C and D: VPDep (20) and VPDel for the 5 lobes of the healthy
(panel C) and emphysematous (panel D) rat lungs. A value of 1 would indicate that deposition/particle delivery was
proportional to the lobe volume.
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